Philogen Overview
- Founded
- 1996

- Status
- Public
- Employees
- 121

- Stock Symbol
- PHIL

- Share Price
- $15.00
- (As of Friday Closing)
Philogen General Information
Description
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.
Contact Information
- Via Bellaria, 35
- 53018 Sovicille
- Italy
Philogen Timeline
Philogen Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$15.00 | $14.66 | $14.07 - $18.70 | $608M | 40.5M | 10K | -$0.46 |
Philogen Financials Summary
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2009 31-Dec-2009 |
---|---|---|---|---|
EV | 538,180 | 538,180 | ||
Revenue | 2,951 | 2,951 | 5,447 | 20,306 |
EBITDA | (15,340) | (15,340) | (11,999) | |
Net Income | (18,592) | (18,592) | (15,144) | |
Total Assets | 150,308 | 150,308 | 105,129 | |
Total Debt | 13,408 | 13,408 | 14,736 |
Philogen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Philogen‘s full profile, request access.
Request a free trialPhilogen Patents
Philogen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3660039-A1 | Il2 immunoconjugates | Withdrawn | 30-Nov-2018 | 00000000000 | 00 |
EP-3749372-A1 | Edb targeting il-12 compositions | Pending | 09-Feb-2018 | 00000000000 | |
CA-3087488-C | Edb targeting il-12 compositions | Active | 09-Feb-2018 | 000000000 | |
AU-2021203986-A1 | Edb targeting il-12 compositions | Pending | 09-Feb-2018 | 000000000 | |
JP-2021513536-A | Edb-targeted il-12 composition | Pending | 09-Feb-2018 | A61K47/6813 |
Philogen Executive Team (4)
Philogen Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000 00 | Self | Board Member | 000 0000 |
00000000 0000000000 | Self | Board Member | 000 0000 |
00000000 0000é | Self | Board Member | 000 0000 |
0000000 000000000 | Self | Board Member | 000 0000 |
0000000 00000000 | Self | Board Member | 000 0000 |
Philogen Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPhilogen Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Philogen‘s full profile, request access.
Request a free trial